United Therapeutics Corporation - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The product portfolio of the company includes Remodulin injection; Tyvaso (treprostinil) inhalation solution; Adcirca (tadalafil) tablets; Unituxin (dinutuximab) injection, and Orenitram (treprostinil) extended-release tablets. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents, and cell-based therapies. United Therapeutics sells products through specialty pharmaceutical distributors across the US. It operates in Europe, Israel and the Middle East, Asia, and South and Central America. The company is headquartered in Silver Spring, Maryland, the US.Scope
- Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
- An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
- Intelligence on United Therapeutics Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on United Therapeutics Corporation's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- United Therapeutics Corporation: Company Overview
- United Therapeutics Corporation: Overview and Key Facts
- United Therapeutics Corporation: Overview
- United Therapeutics Corporation: Key Facts
- United Therapeutics Corporation: Key Employees
- United Therapeutics Corporation: Key Employee Biographies
- United Therapeutics Corporation: Major Products and Services
- United Therapeutics Corporation: Management Statement
- United Therapeutics Corporation: Locations and Subsidiaries
- United Therapeutics Corporation: Key Competitors
- United Therapeutics Corporation: Company Analysis
- United Therapeutics Corporation: Business Description
- United Therapeutics Corporation: SWOT Analysis
- United Therapeutics Corporation: SWOT Overview
- United Therapeutics Corporation: Strengths
- United Therapeutics Corporation: Weaknesses
- United Therapeutics Corporation: Opportunities
- United Therapeutics Corporation: Threats
- United Therapeutics Corporation: Corporate Financial Deals Activity
- United Therapeutics Corporation: Financial Deals Overview
- United Therapeutics Corporation: Targets and Partners
- United Therapeutics Corporation: Top Deals 2020 - 2024YTD*
- United Therapeutics Corporation: Advisors
- United Therapeutics Corporation: Top Legal Advisors
- United Therapeutics Corporation: Mergers and Acquisitions
- United Therapeutics Corporation: Partnership
- United Therapeutics Corporation: Recent Developments
- United Therapeutics Corporation: News and Events Summary
- United Therapeutics Corporation: Financial Performance
- United Therapeutics Corporation: Market Developments
- United Therapeutics Corporation: Regulatory and Legal Events
- United Therapeutics Corporation: Research & Development
- United Therapeutics Corporation: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: United Therapeutics Corporation: Key Facts
- Table 2: United Therapeutics Corporation: Key Employees
- Table 3: United Therapeutics Corporation: Locations and Subsidiaries
- Table 4: United Therapeutics Corporation: Key Competitors
- Table 5: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
- Table 7: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 8: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
- Table 9: United Therapeutics Corporation: Targets and Partners
- Table 10: United Therapeutics Corporation: Top Deals 2020 - 2024YTD*
- Table 11: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
- Table 12: United Therapeutics Corporation: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 13: United Therapeutics Corporation: M&A Activity by Geography (2020 - YTD*2024)
- Table 14: United Therapeutics Corporation: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 15: United Therapeutics Corporation: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 16: United Therapeutics Corporation: News and Events Summary
- Table 17: United Therapeutics Corporation: Financial Performance
- Table 18: United Therapeutics Corporation: Market Developments
- Table 19: United Therapeutics Corporation: Regulatory and Legal Events
- Table 20: United Therapeutics Corporation: Research & Development
- Table 21: United Therapeutics Corporation: Strategy and Operations
- Figure 1: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
- Figure 3: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 4: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
- Figure 5: United Therapeutics Corporation: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 6: United Therapeutics Corporation: M&A Activity by Geography (2020 - YTD*2024)
- Figure 7: United Therapeutics Corporation: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 8: United Therapeutics Corporation: Partnership Trend by Deal Type (2020 - YTD*2024)
